Mesothelioma Research Programme Leicester
  • HOME
  • ABOUT US
    • RESEARCH TEAM
    • RESEARCH FUNDING
    • INDUSTRIAL PARTNERS
    • COLLABORATING INSTITUTIONS
    • USEFUL LINKS
  • WHAT WE DO
    • CLINICAL TRIALS
      • INDUSTRY TRIALS
        • ATOMIC
      • INVESTIGATOR LED STUDIES
        • MARS2
        • VIM
        • CONFIRM
        • FAK PD1 PHASE 1
        • MiST
        • MEDUSA
        • PEACE
    • TRANSLATIONAL RESEARCH
      • MESOTHELIOMA EVOLUTION
      • SPINDLE POISON PHARMACODYNAMICS
      • TARGETING CDKN2A-MTAP
      • MESOTHELIOMA STRATIFIED THERAPY (MiST)
  • PUBLICATIONS
    • SCIENTIFIC PAPERS
    • NEWS
  • CONTACT
    • DONATE
    • FOR HEALTH PROFESSIONALS
    • FOR PATIENTS
    • INDUSTRY
    • CAREER OPPORTUNITIES
    • PRIVACY POLICY
Select Page

Industry Trials

Industry Trials

1st Line
ATOMIC

 

Atomic– Ph 2/3 Study in Subjects With MPM w/Low ASS 1 Expression to Assess ADI-PEG 20 With Pemetrexed and Cisplatin

Mesothelioma Research Programme Leicester University of Leicester University Hospitals of Leicester Leicester Precision Medicine Institute
Website Designed and Developed
by Hyphen and Sandstar